Biopharmaceutical firm AstraZeneca on Thursday said it has expanded its global hub in Bengaluru with an investment of Rs166 ...

When Pascal Soriot flew in to speak at the Boao Forum in China this year, many expected him to keep a low profile. With ...

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...

AstraZeneca has launched a Phase I clinical study titled An Open-label, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 Followi ...

For $45 million upfront, Vor Bio is gaining ex-China rights to RemeGen’s telitacicept, a first-in-class recombinant ...

For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...

The CDC's vaccine advisory committee said it will study the childhood immunization schedule in the first meeting featuring HHS Secretary RFK Jr.'s hand-selected members.

AstraZeneca has expanded its Bengaluru hub with a Rs 166 crore investment, creating 400 jobs to enhance R&D, global services, ...

AstraZeneca has launched a new Global Hub in Bengaluru, investing Rs 166 crore for AI healthcare solutions. This move aims to ...

BlackDoctor Foundation & AstraZeneca unite to fight cancer & lupus. Hear inspiring survivor stories and learn about early ...

Respiratory syncytial virus (RSV) causes severe illness in millions of young children each year.1 Globally, it is estimated that over 100 000 children younger than 5 years die each year from RSV; 97% ...

This was the ADR's second consecutive day of losses.